Thimerosal Vaccine Removal: HHS Finalizes Decision

By HEOR Staff Writer

July 24, 2025

The U.S. Department of Health and Human Services (HHS) has finalized its decision to remove thimerosal from influenza vaccines. This follows a 2025 CDC committee vote to limit thimerosal to single-dose, mercury-free formulations for children, preg...
Comprehensive Review of Type 2 Diabetes Treatment and Diagnosis Strategies
Facilitators and Barriers in AI Medical Imaging Implementation: A Systematic ...
DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expan...
Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression an...
Caution Advised: Conflicts in AAP Childhood Obesity Guidelines
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical ...
ACIP Vaccine Policy Concerns
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
Telemedicine Growth Strategies: Insights from the WHO European Region
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Allopurinol Designated an Orphan Drug for Marfan Syndrome
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...